Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.
Volume 31, Number 11—November 2025
Research Letter
Two Cases of Autochthonous West Nile Virus Encephalitis, Paris, France, 2025
Table
Clinical characteristics for 2 cases of autochthonous West Nile virus, Paris, France*
Characteristics | Patient 1 | Patient 2 |
---|---|---|
Age, y/sex |
64/M |
25/F |
History of travel |
Portugal (2016), Jura (in eastern France) 3 weeks earlier |
None |
Clinical manifestations |
Fever, headache, obnubilation, neck stiffness |
Fever, headache, peripheral facial paralysis, nystagmus, decreased reflexes in lower limbs, urinary retention |
First lumbar puncture | ||
Protein level, g/L (reference <0.40) | 430 | 1,200 |
Leukocyte count, cells/L (reference <0.05) |
1.19; 76% neutrophils |
1.95; 90% lymphocytes |
Second lumbar puncture, time after admission | 4 d | 72 h |
Protein level, g/L (reference <0.40) | 48 | 260 |
Leukocyte count, cells/L (reference <5) |
1.26; 88% lymphocytes |
1.4; 75% lymphocytes |
Brain MRI |
Unremarkable |
Unremarkable |
PCR WNV |
Positive in blood and CSF |
Positive in blood and CSF |
IgM WNV | Positive in blood and CSF | Positive in blood and CSF |
*CSF, cerebrospinal fluid; MRI, magnetic resonance imaging; WNV, West Nile virus.
Page created: August 15, 2025
Page updated: August 20, 2025
Page reviewed: August 20, 2025
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.